tradingkey.logo

M42 Announces Strategic Investment And Partnership With Juvenescence

ReutersApr 16, 2025 9:51 AM

- M42

  • M42 ANNOUNCES STRATEGIC INVESTMENT AND PARTNERSHIP WITH JUVENESCENCE

  • M42 AND JUVENESCENCE WILL COLLABORATE IN DRUG DISCOVERY TO DEVELOP A PIPELINE OF INNOVATIVE MEDICINES to ADVANCE THE PREVENTION AND TREATMENT OF DISEASES OF HIGH UNMET NEED WITHIN UAE AND GLOBALLY AND AGE-RELATED DISEASES

  • M42’S STRATEGIC INVESTMENT IN JUVENESCENCE WILL ACCELERATE JUVENESCENCE’S CLINICAL PIPELINE AND DRUG DEVELOPMENT CAPABILITIES

  • 42 AND JUVENESCENCE WILL FORM A STRATEGIC PARTNERSHIP TO IDENTIFY AND DEVELOP A PIPELINE OF AI-ENABLED THERAPEUTICS TO EXTEND HEALTHY LIFESPAN AND ADVANCE THE TREATMENT OF LIFE-THREATENING DISEASES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI